Abstract:Background: Inflammation is a significant residual risk factor for coronary artery disease. While intensive lipid-lowering therapy has reduced the prevalence of plaque rupture, plaque erosion in acute coronary syndrome (ACS) patients is increasing, with neutrophils playing a crucial role. It remains unclear whether varying low-density lipoprotein cholesterol (LDL-C) levels modify the relationship between neutrophil count and ischemic risk in ACS patients. Aim: To investigate the relationship between neutrophil counts and ischemic risk in ACS patients undergoing percutaneous coronary intervention (PCI) across different LDL-C levels. Methods: This large cohort study enrolled consecutive 10724 patients undergoing PCI at Fuwai Hospital (Peking Union Medical College) throughout the year of 2013. Patients were divided into subgroups according to baseline LDL-C levels, with cut-off points at 1.8mmol/L or 1.4mmol/L. The primary endpoint was major adverse cardiovascular event (MACE), and the secondary endpoint was revascularization. Results: Finally, 5717 ACS patients with PCI were included. The mean age was 58.43 ± 10.35 years, with 4399 (76.9%) being male. During the 5-year follow-up period, 1058 (18.5%) MACEs and 821 (14.4%) revascularizations were recorded. Restricted cubic spline analysis revealed a positive correlation between neutrophil and MACE and revascularizations only in patients with lower LDL-C levels (LDL-C <1.8 and LDL-C <1.4 mmol/L), but not in those with higher LDL-C levels (LDL-C ≥1.8 and LDL-C ≥1.4 mmol/L) (Figure 1) . Multivariate Cox regression analysis showed that in the LDL-C <1.8 mmol/L group, each unit increase in neutrophil count was associated with a 1.129 times higher risk of MACE (HR 1.129; 95% CI 1.046-1.219) and a 1.130 times higher risk of revascularizations (HR 1.130; 95% CI 1.031-1.238). Similar findings were observed in the LDL-C <1.4 mmol/L group, where higher neutrophil was independent risk factors for MACE (HR 1.222; 95% CI 1.063-1.404) and revascularizations (HR 1.274; 95% CI 1.078-1.506). However, in patients with higher LDL-C levels (LDL-C ≥1.8 and LDL-C ≥1.4 mmol/L), neutrophil counts were not associated with outcomes (Table 1) . Conclusions： High neutrophil counts are a significant risk factor for ischemic events in ACS patients with low LDL-C levels, highlighting the potential benefits of targeting neutrophils-related inflammatory pathway in the management of ACS patients with well-controlled LDL-C levels.

Predictive value of peripheral neutrophil count on admission for in- hospital adverse events in young patients with acute coronary syndrome

Predictive value of peripheral neutrophil count on admission for young patients with acute coronary syndrome

Predictive value of the relative lymphocyte count in coronary heart disease

Association of postprocedural neutrophil count and prognosis in ST-elevated myocardial infarction patients after percutaneous coronary intervention

Association Between Percentage of Neutrophils at Admission and In-Hospital Events in Patients ≥75 Years of Age with Acute Coronary Syndrome

Neutrophil-to-Lymphocyte Ratio in Adult Community-Acquired Pneumonia Patients Correlates with Unfavorable Clinical Outcomes

Prognostic value of neutrophil count on early onset congestive heart failure in patients with anterior wall first acute myocardial infarction

Neutrophil Count Improves the Grace Risk Score Prediction of Clinical Outcomes in Patients with St-Elevation Myocardial Infarction

Prognostic Value of the Percentage of Neutrophils on Admission in Patients with ST-elevated Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention.

Abstract 4140810: Impact of Neutrophil on Ischemic Risk in Acute Coronary Syndrome Patients Across Different Low Density Lipoprotein Cholesterol Levels

[Increased Postprocedural Neutrophil Count is an Independent Predictive Factor of Poor Prognosis in Acute ST Elevation Myocardial Infarction Patients Treated with Percutaneous Coronary Intervention].

Neutrophils to high-density lipoprotein cholesterol ratio as a new prognostic marker in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention: a retrospective study

Predictive and Prognostic Value of Admission Neutrophil-to-lymphocyte Ratio in Patients with CHD

Albumin combined with neutrophil-to-lymphocyte ratio score and outcomes in patients with acute coronary syndrome treated with percutaneous coronary intervention

Correlation and Prognostic Role of Neutrophil to Lymphocyte Ratio and SYNTAX Score in Patients with Acute Myocardial Infarction Treated with Percutaneous Coronary Intervention: A Six-Year Experience.

The Admission (Neutrophil+Monocyte)/Lymphocyte Ratio Is an Independent Predictor for In-Hospital Mortality in Patients With Acute Myocardial Infarction

Neutrophil Counts as Promising Marker for Predicting In-Hospital Mortality in Aneurysmal Subarachnoid Hemorrhage

Analysis on neutrophil to lymphocyte ratio in acute coronary syndrome patients

[Predictive value of neutrophil to lymphocyte ratio on long-term outcomes of acute myocardial infarction patients with multivessel disease].

Prediction of the prognosis of patients with acute coronary syndrome by GRACE score combined with neutrophil

Evaluation on white cell count in peripheral blood and plasma C-reactive protein for risk of coronary heart disease